Artificial intelligence - Your MVP On and Off the Field

Today, the number of practicing cardiologists is not keeping pace with the growing demand for cardiovascular care. And, every year, the need for electrocardiogram (ECG) analysis grows by five to twelve percent. Reading ECGs is an iterative process that consumes huge amounts of time that could be better spent with patients.


Idoven is a pioneering health tech company that uses deeply validated artificial intelligence to make things easier for cardiologists and do what humans alone cannot – quickly and accurately interpret extremely large numbers of ECGs.


Celebrated as a soccer icon and named the best goalkeeper in the world five times by the IFFHS, Iker Casillas boasts an illustrious career with Real Madrid and as a World Cup champion. After experiencing a life-altering heart attack during training in 2019, Casillas turned his focus towards a meaningful cause.


He joined forces with Idoven, to early detection of cardiovascular diseases through the use of innovative technology. Together with his foundation, Casillas and Idoven work to raise awareness about the importance of cardiovascular health, promote preventative measures, and improve the diagnostic process for the most vulnerable groups.


During a recent Cardiology Coffee Break, Dr. Manuel Marina Breysse, cardiologist, co-founder and CEO of Idoven, shared details about how Idoven helps clinicians and patients. He also explained how the company is using the power of collaboration to amplify the impact of innovation. Register for the on-demand coffee break to get the full picture.


Watch the coffee break on-demand.

Get access to the on-demand coffee break







    What are the top challenges you are trying to solve with a CVIT solution? (Select all that apply)

    Increase return on investmentImprove patient care experienceImprove productivityIncreased access to patient data and imagesFaster and more informed clinical decisionsStandardize operations and systemsImproved compliant documentation

    Are you interested in implementing a new CVIT solution? If so, when?